Business Daily from THE HINDU group of publications
Saturday, Oct 21, 2006
ePaper


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Management
Industry & Economy - Health
Expert joins LifeCell board

Our Bureau

Chennai , Oct. 20

Dr Amit N. Patel, Director, Centre for Cardiac Cell Theory, and an internationally acclaimed cardiothoracic surgeon and pioneer of stem cell research, has joined the board of directors of the Chennai-based LifeCell.

LifeCell will utilise Dr Patel's expertise for its stem cell operations, including the transplant centre coming up at the Sri Ramachandra Medical College, Chennai.

At a press conference here, Mr S. Abhaya Kumar, Vice-Chairman, LifeCell, said that the company did not want to remain just a "warehouse" for stem cells, but intended to work at the cutting edge of the technology. The induction of Dr Patel, who has performed over 100 adult stem cell surgeries worldwide, would help boost LifeCell's research capabilities, he said.

More Stories on : Management | Health

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
CLB to Bajajs: Settle dispute in a month


Expert joins LifeCell board
Tatas to buy Corus for $8 b
Tatas offer competitive price for Corus shares
Stable rating for Tata Sons NCDs
Chambers welcome deal
Empee Sugars plans expansion
Piped gas: IOC, RIL may form 50:50 joint venture
SIDCO, ITI in pact for `telecom park'
Joint venture pact for Assam gas cracker signed
`Contingent liabilities' against tax litigation, a potential deal breaker
Dengue: Pvt players join fight
Subsidised HIV tests
Our focus is strategic fit, not tonnage: Ratan
Bosch plans Rs 1,800-cr investment


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line